Please ensure Javascript is enabled for purposes of website accessibility

Walgreens to Expand Drive-Thru COVID-19 Testing

By Cory Renauer - Updated Apr 7, 2020 at 2:32PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Walgreens Boots Alliance will soon begin offering rapid coronavirus tests at 15 new sites across seven states.

On Tuesday, Walgreens Boots Alliance (WBA 1.26%) announced plans to expand a drive-thru coronavirus testing service that can provide rapid results while customers wait. The company's pharmacists will run patient samples through Abbott's (ABT -0.23%) ID NOW machines, which can provide results in less than 15 minutes.   

Walgreens opened its first drive-through testing location in March and is still finalizing plans for the next 15 locations. The company is working with the Department of Health and Human Services to select hot spots in Arizona, Florida, Illinois, Kentucky, Louisiana, Tennessee, and Texas.

COVID-19 test

Image source: Getty Images.

Abbott's toaster-sized testing machines are already popular because they can amplify genetic material from patient samples without the long incubation process that slows down most molecular testing services. The ID NOW COVID-19 test can tell if a sample is positive in as little as 5 minutes, and give a negative result within 13 minutes.

Not to be outdone

This move will make Walgreens the second retail pharmacy chain in the U.S. to offer drive-thru COVID-19 testing at multiple locations. On Monday, CVS Health (CVS -0.25%) began providing Abbott's ID NOW COVID-19 test in two parking lots outside of retail medical clinics it operates in Rhode Island and Georgia.

Between them, CVS Health and Walgreens could do a lot to ramp up the country's testing capacity. Walgreens plans to test up to 3,000 people per day across those 15 locations. CVS Health expects each  of its drive-thru testing sites will be able to process thousands of samples daily.

Cory Renauer has no position in any of the stocks mentioned. The Motley Fool recommends CVS Health. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Walgreens Boots Alliance, Inc. Stock Quote
Walgreens Boots Alliance, Inc.
WBA
$39.48 (1.26%) $0.49
Abbott Laboratories Stock Quote
Abbott Laboratories
ABT
$109.00 (-0.23%) $0.25
CVS Health Corporation Stock Quote
CVS Health Corporation
CVS
$102.00 (-0.25%) $0.26

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
377%
 
S&P 500 Returns
123%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 08/09/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.